• floofloof@lemmy.ca
    link
    fedilink
    English
    arrow-up
    33
    arrow-down
    1
    ·
    edit-2
    1 year ago

    In 8 of 16 patients studied, the vaccines activated T cells that recognize the patient’s own pancreatic cancers. These patients also showed delayed recurrence of their pancreatic cancers, suggesting the T cells activated by the vaccines may be having the desired effect to keep pancreatic cancers in check.

    Good news, but the headline lacks nuance.

      • Seytoux@lemmy.one
        link
        fedilink
        arrow-up
        9
        arrow-down
        1
        ·
        1 year ago

        Same, this big catchy over optimistic and click bait headlines make me automatically really suspicious of the claims. Great news if the second trial goes well

        • ikiru@lemmy.ml
          link
          fedilink
          arrow-up
          1
          ·
          1 year ago

          I’m old enough to know from countless sensationalized headlines that most if not all newly announced alleged medical breakthroughs will never reach the public, at least not anyone without at least millions of dollars.

          I’m also not that old.